Company

Ykrita LifeSciences Private Limited

Ykrita Lifesciences develops a bio-engineered device intended to support liver function without surgery.

About

Ykrita Lifesciences develops Bio-Engineered Artificial Ectopic Liver devices designed to supplement liver function by converting somatic cells into hepatocytes. Founded in 2020 by Dr. Mahesh Gopasetty, the company is based in Karnataka, India. In November 2021, it raised INR 90 million in seed funding co-led by Indian Scientific Innovation Company Limited and Venture Catalysts.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in